lonazolac

This page covers all lonazolac drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Prostaglandin E synthase.

Targets

Prostaglandin E synthase

Phase 2 pipeline (1)

• LONAZOLAC · Immunology
  LONAZOLAC works by inhibiting the enzyme Prostaglandin E synthase, which plays a role in the production of prostaglandins.

Patent intelligence

• lonazolac patent landscape — aggregated cliff calendar, attackable patents, originator estates